Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7741916 | 0.90 | — | — | |
| SCHEMBL28568833 | 0.76 | TSHR (0.36) | TSHRNFKB1CYP2C19 | |
| SCHEMBL25270882 | 0.76 | TSHR (0.40) | TSHRNFKB1CYP2C19 | |
| SCHEMBL11553274 | 0.75 | GAA (0.40) | — | |
| SCHEMBL27522393 | 0.74 | TSHR (0.35) | TSHRNFKB1CYP2C19 | |
| SCHEMBL6678762 | 0.73 | GAA (0.30) | — | |
| SCHEMBL1305578 | 0.73 | TSHR (0.33) | TSHRNFKB1CYP2C19 | |
| SCHEMBL4442630 | 0.71 | HDAC8 (0.34) | TSHRNFKB1CYP2C19 | |
| SCHEMBL19463652 | 0.71 | TSHR (0.34) | TSHRNFKB1CYP2C19 | |
| SCHEMBL4747481 | 0.70 | TSHR (0.32) | TSHRNFKB1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11225584-B2 | Adhesion promoter system, and method of producing the same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-01-18 | — | — | US | disclosed |
| EP-3312248-B1 | ADHESION PROMOTER SYSTEM, AND METHOD OF PRODUCING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-10-14 | — | — | EP | disclosed |
| US-10618991-B2 | Reprocessable cross-linked network polymers with alkoxyamine dynamic covalent bonds | NORTHWESTERN UNIVERSITY (US) | 2020-04-14 | — | — | US | disclosed |
| EP-3312248-A1 | ADHESION PROMOTER SYSTEM, AND METHOD OF PRODUCING THE SAME | Dow Global Technologies Llc (US) | 2018-04-25 | — | — | EP | disclosed |
| EP-2569382-B1 | ADHESION PROMOTER SYSTEM, AND METHOD OF PRODUCING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-01-17 | — | — | EP | disclosed |
| EP-2569374-B1 | ADHESION PROMOTER SYSTEM, AND METHOD OF PRODUCING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-08-23 | — | — | EP | disclosed |
| WO-2017053803-A1 | REPROCESSABLE CROSS-LINKED NETWORK POLYMERS WITH ALKOXYAMINE DYNAMIC COVALENT BONDS | NORTHWESTERN UNIVERSITY (US) | 2017-03-30 | — | — | WO | disclosed |
| US-20170081449-A1 | Reprocessable Cross-linked Network Polymers with Alkoxyamine Dynamic Covalent Bonds | NORTHWESTERN UNIVERSITY | 2017-03-23 | — | — | US | disclosed |
| US-8987410-B2 | Terminal unsaturated, glycidol-based macromonomers, polymers obtainable therefrom, preparation and use | BYK-CHEMIE GMBH (DE) | 2015-03-24 | — | — | US | disclosed |
| EP-2443170-B1 | TERMINAL UNSATURATED, GLYCIDOL BASED MACROMONOMERS, POLYMERS OBTAINABLE THEREFROM, PRODUCTION AND USE THEREOF | BYK CHEMIE GMBH (DE) | 2013-04-03 | — | — | EP | disclosed |
| EP-1802316-B1 | PURINE DERIVATIVES AND METHODS OF USE THEREOF | INOTEK PHARMACEUTICALS CORP (US) | 2011-11-02 | — | — | EP | disclosed |
| US-20110059915-A1 | PURINE DERIVATIVES AND METHODS OF USE THEREOF | INOTEK PHARMACEUTICALS CORPORATION (US) | 2011-03-10 | — | — | US | disclosed |
| EP-2264082-A1 | Terminal unsaturated glycidol-based marcomonomers, polymers obtained from them, manufacture and use | BYK-Chemie GmbH (DE) | 2010-12-22 | — | — | EP | disclosed |
| EP-1996020-A2 | PURINE COMPOUNDS AND METHODS OF USE THEREOF | Inotek Pharmaceuticals Corporation (US) | 2008-12-03 | — | — | EP | disclosed |
| US-20070238694-A1 | Purine compounds and methods of use thereof | INOTEK PHARMACEUTICALS CORPORATION (US) | 2007-10-11 | — | — | US | disclosed |
| WO-2007111954-A2 | PURINE COMPOUNDS AND METHODS OF USE THEREOF | INOTEK PHAMACEUTICALS CORPORATION (US) | 2007-10-04 | — | — | WO | disclosed |
| EP-1802316-A2 | PURINE DERIVATIVES AND METHODS OF USE THEREOF | Inotek Pharmaceuticals Corporation (US) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006034190-A2 | PURINE DERIVATIVES AND METHODS OF USE THEREOF | INOTEK PHARMACEUTICALS CORPORATION (US) | 2006-03-30 | — | — | WO | disclosed |
| US-6787621-B2 | USING DIARYLETHENE MONOMERS FOR MAKING PHOTOCHROMIC POLYMERIZABLE THIN FILM | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2004-09-07 | — | — | US | disclosed |
| US-20030130456-A1 | Vinyl group-containing diarylethene and polymer thereof having excellent optical properties | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY | 2003-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238694-A1 | Purine compounds and methods of use thereof | PNP, ADORA2A, P2RY1 | TSHR 4003/4885NFKB1 999/4885CYP2C19 2147/4885 |
| US-20110059915-A1 | PURINE DERIVATIVES AND METHODS OF USE THEREOF | PNP, NUDT1, HPRT1 | TSHR 4281/4885NFKB1 918/4885CYP2C19 1928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.